about
Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells.Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosisDivergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study.Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.VEGF-targeted therapy stably modulates the glycolytic phenotype of tumor cells.A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer.Validation of an engineered cell model for in vitro and in vivo HIF-1α evaluation by different imaging modalities.Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.Characterization of preclinical models of prostate cancer using PET-based molecular imaging.Glycine N-methylation in NGR-Tagged Nanocarriers Prevents Isoaspartate formation and Integrin Binding without Impairing CD13 Recognition and Tumor Homing.The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis.Therapeutic antibody targeting of Notch1 in T-acute lymphoblastic leukemia xenografts.Regional Differences in Cerebral Glucose Metabolism After Cardiac Arrest and Resuscitation in Rats Using [(18)F]FDG Positron Emission Tomography and Autoradiography.Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models.A Decision Support System for the assisted diagnosis of brain tumors: a feasibility study for ¹⁸F-FDG PET preclinical studies.Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis.Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using (18)F-FDG PET
P50
Q27333517-73E0BA24-B4DA-4A5C-B0A6-66A7817BC6D3Q37012644-FE7F6764-42A7-4F8F-B517-E8FA4279531DQ37588402-C46C0374-8513-4985-94F3-C84DDF3B5EB7Q38739226-8C4D2565-77C1-423A-97BC-E53DE5D4D1EFQ38894617-ABFBD776-7A9B-4A13-8F1F-DFF92BF0DD43Q38941727-9A0475F4-7337-45FF-A6B7-766343C7A587Q38964866-1A61D371-B148-472D-B4CA-E6E02D9719B3Q39100551-4CEEC576-0558-4822-8783-89DB79D11ED9Q39148442-4EB49DAA-46CD-4771-9046-0790CB75DA3AQ39874026-95ECB43C-3A75-4F0A-8FE1-F72C8FDE7F2DQ42287023-A8E51214-8F28-4FBB-8840-7ADDD72EF1EDQ44198742-EF5ACAF0-D6AC-4CE7-B112-211F81EC0920Q45735200-F137FB36-CBEC-4CFB-9B38-C0CB7DB596ABQ47256103-1D535BC9-3B05-46AE-B054-E577C76652B6Q47852873-FC33EB5C-B302-4DAF-97F4-2FDD96C36846Q48183452-ABF6041A-2161-40C9-B0E1-51A642A373C7Q51743298-A86913B6-3A59-452C-B4E9-9F641829DE6FQ82299306-51C467F5-5271-415A-90D0-7E6DE834886F
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-2871-6046
@en
name
Silvia Valtorta
@ast
Silvia Valtorta
@en
Silvia Valtorta
@es
Silvia Valtorta
@nl
type
label
Silvia Valtorta
@ast
Silvia Valtorta
@en
Silvia Valtorta
@es
Silvia Valtorta
@nl
prefLabel
Silvia Valtorta
@ast
Silvia Valtorta
@en
Silvia Valtorta
@es
Silvia Valtorta
@nl
P106
P21
P31
P496
0000-0003-2871-6046